Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/10/1996US5583143 Administering a 2,3-diaryl-1-benzopyran
12/10/1996US5583142 Analgesic and nootropic drugs
12/10/1996US5583141 Heterocyclic compounds and their use as angiotensin antagonists
12/10/1996US5583139 Marcolide immunomodulators
12/10/1996US5583138 Reductase inhibitor; skin disorders
12/10/1996US5583137 Heterocyclic compounds for enhancing antitumor activity
12/10/1996US5583136 Retinoid containing skin care compositions containing imidazoles
12/10/1996US5583135 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/10/1996US5583133 Anticoagulants
12/10/1996US5583132 Hiv infections, aids
12/10/1996US5583130 Benzo-fused lactams promote release of growth hormone
12/10/1996US5583129 Composition for contraception
12/10/1996US5583128 Contraception in female primates without affecting the menstrual cycle
12/10/1996US5583127 17-iminomethylalkenyl-5 β, 14 β-androstane and 17-iminoalkyl-5 β, 14 β-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containing same
12/10/1996US5583126 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5583121 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
12/10/1996US5583120 Applying to cutis tissues in treatment of dermatitis
12/10/1996US5583119 Hyaluronic acid-urea pharmaceutical compositions and uses
12/10/1996US5583118 Topical application of mixture in carrier
12/10/1996US5583117 Acylated uridine and cytidine for elevating tissue uridine and cytidine
12/10/1996US5583115 Dialkyltiacumicin compounds
12/10/1996US5583113 Use of a direct-acting thrombin inhibitor for the manufacture of a medicinal product having thrombolytic activity
12/10/1996US5583112 Enhancing immune responses in animals
12/10/1996US5583105 Oral pharmaceutical preparation
12/10/1996US5583101 S-nitroso amino acids
12/10/1996US5583019 Culturing microorganisms of the genus mortierella sect. schmuckeri; recovering microorganisms
12/10/1996US5583018 Rapamycin derivative process for its preparation and its use
12/10/1996US5583000 Protease-binding compounds and methods of use
12/10/1996US5582972 Antisense oligonucleotides to the RAS gene
12/10/1996US5582839 Administering intravenously to treat chronic cardiac condition such as myocardial infarction
12/10/1996US5582835 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
12/10/1996US5582832 Compositions for topical application to skin
12/10/1996US5582828 Active fractions of Cordyceps sinensis and method of isolation thereof
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996US5582822 Cyclic administration of purified genetically engineered human interleukins
12/10/1996US5582817 Organozinc compounds
12/10/1996US5582592 Topical application of steroid hormones and vaginocervical stimulation to induce maternal behavior of animals
12/10/1996US5582591 Delivery of solid drug compositions
12/10/1996US5582589 Medical probe with stylets
12/10/1996CA2178548A1 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydro-quinazolinedione derivatives as .alpha.1 adrenergic receptor antagonists
12/10/1996CA2114727C Quinoline derivatives as immunostimulants
12/10/1996CA2104456C Pyridine- and imidazole-derived agents for cardiovascular diseases
12/10/1996CA2082270C Anti-viral therapy
12/10/1996CA2039420C Treatment of cataract with 15-keto-prostaglandin compounds
12/10/1996CA2032254C Glycerol derivatives, a preparation process of the same and therapeutical compositions containing them
12/10/1996CA2032224C 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a preparation process of the same and therapeutical compositions containing them
12/10/1996CA2023217C Azabicyclo quinolone carboxylic acids
12/10/1996CA2007983C Coenzyme q10 with hmg-coa reductase inhibitors
12/10/1996CA1338789C 3,4-disubstituted phenyl heterocycles and their use
12/10/1996CA1338786C (aryl or heteroaromatic methyl)-2,2'-bi-1h-imidazoles
12/10/1996CA1338780C Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
12/10/1996CA1338779C Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
12/08/1996CA2178414A1 Dihydropyridine npy antagonists: nitrogen heterocyclic derivatives
12/08/1996CA2178413A1 Dihydropyridine npy antagonists: piperazine derivatives
12/08/1996CA2178355A1 Diazepine containing dual action inhibitors
12/08/1996CA2178353A1 Sulfonamido substituted benzopyran derivatives
12/08/1996CA2178352A1 Thiazolo benzazepine containing dual action inhibitors
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178183A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2177110A1 Dihydropyridine npy antagonists: piperidine derivatives
12/08/1996CA2176854A1 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
12/08/1996CA2173172A1 Petroleum jelly with inositol phosphates
12/07/1996CA2178361A1 Ethylamido fluorenes and improved method of making same
12/07/1996CA2176191A1 Prodrugs of paclitaxel derivatives
12/07/1996CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives
12/05/1996WO1996038579A1 High-affinity oligonucleotide ligands to growth factors
12/05/1996WO1996038548A1 Oxygen activatable formulations for disinfection or sterilization
12/05/1996WO1996038473A2 Antimicrobial cationic peptides
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038470A1 IMIDAZO[1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/05/1996WO1996038461A1 Cleavage of rna using metal complexes
12/05/1996WO1996038460A1 Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038449A1 Water soluble camptothecin analogs
12/05/1996WO1996038446A1 Fused polycyclic heterocycle derivatives
12/05/1996WO1996038444A1 Oxazolidinone derivatives, their preparation and therapeutical use
12/05/1996WO1996038441A1 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds
12/05/1996WO1996038439A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them
12/05/1996WO1996038437A1 Process for the production of lipoic acid
12/05/1996WO1996038436A1 (2-thienyl)alkanoic acid derivatives
12/05/1996WO1996038434A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996WO1996038431A1 Process for making heterocyclic compounds
12/05/1996WO1996038430A1 Process for making heterocyclic compounds
12/05/1996WO1996038428A1 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038421A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
12/05/1996WO1996038417A1 N-oxides as antibacterial agents
12/05/1996WO1996038416A1 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
12/05/1996WO1996038415A1 Novel 2-amino-3-phenylpropionic acid derivatives
12/05/1996WO1996038414A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response
12/05/1996WO1996038412A1 Novel compounds and anti-dermatitis drug
12/05/1996WO1996038186A1 Chemotherapeutic compositions
12/05/1996WO1996038175A1 Stabilized composition comprising an antiulcerative benzimidazole
12/05/1996WO1996038174A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996WO1996038173A1 Brain edema inhibitor
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038165A2 Endoparasiticidal agents
1 ... 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 ... 7860